跳至主要内容
临床试验/NL-OMON30525
NL-OMON30525尚未招募不适用

Correlation between SV2A expression in tumour tissue and efficacy of levetiracetam in glioma patients with epilepsy. - SV2A expression and levetiracetam response in glioma patients.

Vrije Universiteit Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • We will include adult (> 18 years) glioma patients who suffered from partial seizures, with or without secondary generalisation, preoperatively. Patients must have undergone surgery for their newly-diagnosed or recurrent glioma not more than 42 days previously and be treated with levetiracetam monotherapy at the time of inclusion.

排除标准

  • Patients who do not have a basic proficiency of the Dutch language, or are unable to communicate adequately (e.g. due to dysphasia) will be excluded.

研究者

相似试验

Correlation between SV2A expression in tumour tissue... | 临床试验